Figures obtained under an FOI request show the NHS spent a whopping £250million in the past five years on treatment for trans ...
Sigma Planning Corp reduced its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 11.0% during the fourth quarter, according to its most recent disclosure with the Securities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback